A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and Tolerability
Launched by LG CHEM · Dec 18, 2024
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adults aged 19 to 40years at screening.
- • Voluntarily decide to participate and provide written informed consent.
- • Able to receive the investigational product (IP) and pre-treatment drugs.
- • Wiliing and able to comply with study requirements, including follow-up visits and blood/urine sampling.
- Exclusion Criteria:
- • History of conditions contraindicating somatropin or pre-treatment drugs.
- • Clinically significant medical history.
- • Participation in another clinical trial and receipt of an investigational product within 80 days prior to the first IP administration.
About Lg Chem
LG Chem is a leading global chemical and advanced materials company based in South Korea, recognized for its commitment to innovation and sustainability in the life sciences sector. With a robust portfolio that spans pharmaceuticals, biotechnology, and advanced materials, LG Chem leverages cutting-edge research and development to drive breakthroughs in healthcare. The company is dedicated to improving patient outcomes through the development of novel therapies and drug delivery systems, underscoring its mission to enhance quality of life through science and technology. As a clinical trial sponsor, LG Chem prioritizes rigorous scientific standards and ethical practices to ensure the safety and efficacy of its therapeutic candidates.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, Seoul Teugbyeolsi, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported